Literature DB >> 21455431

Vesiculobullous eruption of the right arm after intravenous clarithromycin.

Abdulkadir Kuçukbayrak1, Engin Senel, Zeynep Seckin Kücükbayrak, Ersin Gunay, Ezgi Simsek.   

Abstract

Clarithromycin is a macrolide antibiotic. In clinical trials, adverse drug reactions of clarithromycin are usually mild and transient. Only 1% of the adverse reactions are severe. Herein, we present a case with vesiculobullous skin reaction and vein thrombosis caused by administration of intravenous clarithromycin.

Entities:  

Keywords:  Adverse drug reaction; bullous reaction; clarithromycin; intravenous; venous thrombosis

Year:  2011        PMID： 21455431      PMCID： PMC3062131          DOI： 10.4103/0253-7613.75679

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN： 0253-7613            Impact factor:   1.200


  5 in total

Review 1.  The tolerance and toxicity of clarithromycin.

Authors:  M J Wood
Journal:  J Hosp Infect       Date:  1991-09       Impact factor: 3.926

2.  Anaphylactic reaction to clarithromycin in a child.

Authors:  M Ben-Shoshan; A Moore; M N Primeau
Journal:  Allergy       Date:  2009-02-16       Impact factor: 13.146

3.  Endothelial cell compatibility of clarithromycin for intravenous use.

Authors:  H Vorbach; G Weigel; B Robibaro; C Armbruster; R Schaumann; M Hlousek; M Reiter; A Griesmacher; A Georgopoulos
Journal:  Clin Biochem       Date:  1998-11       Impact factor: 3.281

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.

Authors:  D Genné; H H Siegrist; L Humair; B Janin-Jaquat; A de Torrenté
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 5.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.